Related Experiment Video
Updated: Nov 2, 2025

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
Long non‑coding RNA 00858 knockdown alleviates bladder cancer via regulation of the miR‑3064‑5p/CTGF axis
Ji Huang1, Qiu-Ming He2, Qi Wu3
1Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China.
Abstract:
The long non-coding RNA 00858 (LINC00858) has been reported to be an oncogene for various cancer diseases, including osteosarcoma and colorectal cancer. However, the expression pattern and function of LINC00858 in bladder cancer remain largely unknown. The expression level of LINC00858 was measured in tumor tissues and cell lines by RT-qPCR. The role of LINC00858 in bladder cancer cells were studied by gain- and loss-of-function strategies in vitro. Cell proliferation, migration and invasion were assessed by CCK-8, colony formation, wound healing and Transwell chamber assays. At the molecular level, dual luciferase reporter and RNA RIP assays were performed to identify the interaction among LINC00858, microRNA (miR)-3064-5p and cellular communication network factor 2 (CTGF). The results revealed that the expression level of LINC00858 was upregulated in bladder cancer tissues and cell lines including T24, J82 and 5637. Moreover, knockdown of LINC00858 suppressed cell proliferation, migration and invasion in vitro. Mechanistically, LINC00858 functioned as a competitive RNA to increase the expression level of oncogene CTGF by sequestering miR-3064-5p. In conclusion, LINC00858 knockdown inhibited the proliferation, migration and invasion of bladder cancer cells via regulation of the miR-3064-5p/CTGF axis.
Insights
Long non-coding RNA 00858 (LINC00858) is upregulated in bladder cancer, promoting tumor cell proliferation, migration, and invasion. Inhibiting LINC00858 may offer a therapeutic strategy for bladder cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Long non-coding RNA 00858 (LINC00858) is implicated as an oncogene in osteosarcoma and colorectal cancer.
- The role and expression of LINC00858 in bladder cancer are not well understood.
Purpose of the Study:
- To investigate the expression pattern and functional role of LINC00858 in bladder cancer.
- To elucidate the molecular mechanism underlying LINC00858's function in bladder cancer.
Main Methods:
- Quantitative reverse transcription polymerase chain reaction (RT-qPCR) to measure LINC00858 expression.
- In vitro gain- and loss-of-function studies (cell proliferation, migration, invasion assays).
- Dual luciferase reporter and RNA immunoprecipitation (RIP) assays to identify molecular interactions.
Main Results:
- LINC00858 expression was significantly upregulated in bladder cancer tissues and cell lines.
- LINC00858 knockdown inhibited bladder cancer cell proliferation, migration, and invasion.
- LINC00858 acts as a competing endogenous RNA, sequestering miR-3064-5p to upregulate the oncogene CTGF.
Conclusions:
- LINC00858 promotes bladder cancer progression by regulating the miR-3064-5p/CTGF axis.
- Targeting LINC00858 could be a potential therapeutic strategy for bladder cancer.
Related Concept Videos
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs
